SynAgile Completes Enrollment of its Phase 2 Clinical Trial

SAN JOSE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- SynAgile Corporation (www.SynAgile.com) is pleased to announce it has completed enrollment of its...

Related Keywords

Luxembourg , Italy , California , United States , Spain , Ephraim Heller , Synagile Corporation , Agile Corporation , Dopafuse Delivery System , Continuous Oral Levodopa , Dopafuse System , San Jose , Chief Executive ,